NDC 55513-100

TEZSPIRE

Tezepelumab-ekko

TEZSPIRE is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Amgen, Inc. The primary component is Tezepelumab.

• Product ID: 55513-100_25a4a901-927c-4f3a-a1c4-72826d46e946
• NDC: 55513-100
• Product Type: Human Prescription Drug
• Proprietary Name: TEZSPIRE
• Generic Name: Tezepelumab-ekko
• Dosage Form: Injection, Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2021-12-17
• Marketing Category: BLA /
• Application Number: BLA761224
• Labeler Name: Amgen, Inc
• Substance Name: TEZEPELUMAB
• Active Ingredient Strength: 210 mg/1.9mL
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 55513-100-01

1 VIAL, GLASS in 1 CARTON (55513-100-01) > 1.91 mL in 1 VIAL, GLASS

• Marketing Start Date: 2021-12-17
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "TEZSPIRE" or generic name "Tezepelumab-ekko"

NDC	Brand Name	Generic Name
55513-100	TEZSPIRE	tezepelumab-ekko
55513-112	TEZSPIRE	tezepelumab-ekko